NCT02146495View on ClinicalTrials.gov

Targeted Limbic Self-modulation as a Potential Treatment for Patients Suffering From Fibromyalgia

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Fibromyalgia (FM)
Interventions
DEVICE

Simultaneous EEG and fMRI recordings

DEVICE

Amygdala-Electrical Fingerprint (Amyg-EFP)-NF Trial

Neurofeedback training utilizing Amygdala Electrical Fingerprint (Amyg-EFP) methodology

DEVICE

Amygdala-Electrical Fingerprint (Amyg-EFP)-NF Sham Trial

Sham neurofeedback training based on a randomized artificial Amyg-EFP signal.

Trial Locations (1)

Unknown

Tel Aviv Sourasky Medical Center, Tel Aviv

All Listed Sponsors
lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT02146495 - Targeted Limbic Self-modulation as a Potential Treatment for Patients Suffering From Fibromyalgia | Biotech Hunter | Biotech Hunter